Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AC-201 in Type 2 Diabetes Mellitus
NCT01276106Phase 2Completed
- Sponsor
- TWi Biotechnology, Inc.
- Start
- Jan 2011
- Primary completion
- Feb 2012
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of AC-201CR in type 2 diabetes mellitus (T2DM), sponsored by TWi Biotechnology, Inc.. Started Jan 2011; status: completed.
02
Drugs
AC-201CR
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01276106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01276106.